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ABSTRACT 
THE EFFECT OF ADJUVANT SUBCONJUNCTIVAL 
DEXAMETHASONE THERAPY ON INTERLEUKIN-6 (IL-6) AND 
TRANSFORMING GROWTH FACTOR BETA 2 (TGF-β2) IN 
PROLIFERATIVE VITREORETINOPATHY GRADE B-C VITREOUS 
FLUID  
 
(Experimental Study in Rhegmatogenous Retinal Detachment patients at DR 
Soetomo Hospital Surabaya) 
 
Objective: To evaluate IL-6 and TGF-β2 levels in the vitreous of PVR grade B-C 
with rhegmatogenous retinal detachment patients that were given subconjunctival 
dexamethasone adjuvant therapy compared to the group who received no adjuvant 
therapy at RSUD Dr. Soetomo Surabaya. 
 
Material and Methods: In this experimental study, 36 patients were enrolled and 
randomly assigned to two groups: adjuvant subconjunctival dexamethasone 10 mg 
(treatment group: 20 patients) and no adjuvant therapy (control group: 16 
patients). Group A (20 patients) was given adjuvant therapy with subconjunctival 
dexamethasone 10 mg as treatment group, and Group B (16 patients) was not 
given adjuvant therapy as control group.  Dexamethasone 10 mg adjuvant therapy 
was given 5-6 hours before vitrectomy and vitreous samples were collected by 
pars plana primary vitrectomy. All vitreous samples were immediately frozen at -
80º C. Vitreous levels of IL-6 and TGF-β2 were measured using Human sandwich 
ELISA. The outcomes were analyzed  using the Mann-Whitney test. 
 
Results: The mean intravitreal IL-6 level was 334.23 pg/ml in the treatment group 
and the mean intravitreal IL-6 level in the control group was 157.52 pg/ml. The 
mean intravitreal TGF-β2 level was 223.93 pg/ml in the treatment group and the 
mean intravitreal TGF-β2 level in the control group was 151.85 pg/ml. 
 
Conclusion: There was no significant differences between the reduction of IL-6 
and TGF-β2 levels in the treatment group and the control group.  
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